SMARCD1 and neoplasm: In addition, related studies have reported that ARID2, SMARCC1, SMARCD1‐3 and other subunits have a low mutation probability in tumours, which is manifested as delection.20, 21, 22, 23, 24, 25, 26, 27, 28